MedTrace Logo

Fascial-muscular Lengthening Therapy in the Patients With Chronic Low Back Pain.

NCT04760366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2021-09-23

No results posted yet for this study

Summary

The purpose of this study is to assess and evaluate tight iliopsoas muscle in patients with chronic low back pain and to increase hip flexor flexibility in the patients with chronic low back pain by using the technique of manual fascial-muscular lengthening therapy .

Conditions

  • Chronic Low Back Pain

Interventions

OTHER

fascial- muscular lengthening therapy

Patients in this group will receive interventional therapy To perform this technique: 1. Have the patient in side lying position 2. Hip is maximally flexed to shorten the iliopsoas muscle. 3. Therapist fingers should be on to the targeted area. 4. Apply gentle pressure in upward direction. 5. While maintain the pressure, stretch the muscle by moving the hip in extension through full ROM. 6. Therapist will maintain the pressure in opposing direction. This is considered as one pass. This technique is performed bilaterally. Patients in this group will also receive the conventional therapy which will include: * Hot pack for 15 minutes. * Myofascial release of iliopsoas. * TENS for 15 minutes.

OTHER

Stretching's of iliopsoas muscle

Patients in this group will receive the interventional therapy which will include: Stretching's of iliopsoas muscle which can be done in two positions: 1. modified lunge position. 2. The prone stretch. Patients in this group will also receive the conventional therapy which will include: * Hot pack for 15 minutes. * Myofascial release of iliopsoas * TENS for 15 minutes.

OTHER

the conventional therapy

the conventional therapy

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Shafaq Shahid, MSPT-OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-13
Primary Completion
2021-03-20
Completion
2021-03-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04760366 on ClinicalTrials.gov